You are here

Article Text

Article menu
Download PDFPDF
ORIGINAL ARTICLE
Future opportunities of the Gynecological Cancer Intergroup
  1. G. C.E. Stuart
  1. Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
  1. Address correspondence and reprint requests to: Gavin C.E. Stuart, MD, Dean, Faculty of Medicine, University of British Columbia, 317-2194 Health Sciences Mall, Vancouver, BC V6T 1Z3. Email: gstuart{at}medd.med.ubc.ca

Abstract

The Gynecologic Cancer Intergroup (GCIG) is an international collaboration of cooperative clinical trials groups who conduct randomized phase III clinical trials in the population of women affected by gynecologic cancer. This collaboration amongst 18 member groups allows for rapid accrual of women to such trials with outcomes that are rapidly generated and readily generalizable to a broad population. Future considerations should include studies in prevention and translational research through improved processes and new global partnerships

  • clinical trials
  • intergroup
  • phase III trials

http://dx.doi.org/10.1111/j.1525-1438.2007.01108.x

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.